A study to establish the feasibility and safety of using XR technology to identify tumor location in the lung for sublobar resection.

An exploratory study of lung tumor location identification using extended reality-aided marking - Extended reality-aided tumor marking

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050240040

Enrollment

Registered

2024-05-21

Start date

2023-11-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung malignant tumor

Interventions

Extended reality, Sublobar resection, Marking

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Lung malignant tumor patients who will receive thoracoscopic sublobar resection. 2. The patints with 18 years old or more, and 79 years old or less 3. The patients having provided signed informed consent. 4. The patients who have had blood examination (white blood cells, hemoglobin, platelets, total bilirubin, AST, ALT, serum creatinine, CRP) ,chest X-ray and CT scan of chest with 56 days

Exclusion criteria

Exclusion criteria: 1. The pregnant patients. 2. The patients with psychiatric disorders or psychiatric symptoms that interfere with daily life and make participation in the study difficult. 3. The patients who are judged to be eligible by investigators.

Design outcomes

Primary

Measure	Time frame
The difference between the actual distance from the tumor to the margin and the distance from the identified marking point on the extended reality image to the margin.	—

Secondary

Measure	Time frame
Duration of surgery Adverse events	—

Contacts

Public ContactTane Shinya

Kobe University Graduate School of Medicine

tanakay@med.kobe-u.ac.jp+81-78-382-5750

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026